{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:54:14Z","timestamp":1785466454913,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100013988","name":"Dermira","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013988","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13555-022-00861-4","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T04:31:55Z","timestamp":1670905915000},"page":"315-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)"],"prefix":"10.1007","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct02326298","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02326272","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Paolo","family":"Gisondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boni","family":"Elewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsen-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"de la Loge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Fierens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"L\u00f3pez Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4705-5303","authenticated-orcid":false,"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"861_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7525-4-35","volume":"4","author":"MJ Bhosle","year":"2006","unstructured":"Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"861_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1203475416648323","volume":"20","author":"M Gooderham","year":"2016","unstructured":"Gooderham M, Gavino-Velasco J, Clifford C, MacPherson A, Krasnoshtein F, Papp K. A review of psoriasis, therapies, and suicide. J Cutan Med Surg. 2016;20(4):293\u2013303.","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"861_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2018.1401468","volume":"14","author":"J Frieder","year":"2018","unstructured":"Frieder J, Kivelevitch D, Fiore CT, Saad S, Menter A. The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis. Expert Rev Clin Immunol. 2018;14(1):1\u201319.","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"861_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, et\u00a0al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029\u201372.","journal-title":"J Am Acad Dermatol"},{"key":"861_CR5","unstructured":"NICE. NICE Pathways: Psoriasis overview. Available at: https:\/\/pathways.nice.org.uk\/pathways\/psoriasis [last accessed Apr 29 2022]."},{"issue":"2","key":"861_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/1203475418808764","volume":"23","author":"A Ighani","year":"2019","unstructured":"Ighani A, Yu AM, Sandhu VK, Barankin B, Manolson MF. Satisfaction and awareness of systemic psoriasis treatments: a national survey comparing biologic and nonbiologic users. J Cutan Med Surg. 2019;23(2):148\u201356.","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"861_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/09546634.2013.826341","volume":"25","author":"EC Levin","year":"2014","unstructured":"Levin EC, Gupta R, Brown G, Malakouti M, Koo J. Biologic fatigue in psoriasis. J Dermatol Treat. 2014;25(1):78\u201382.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"861_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/bjd.19393","volume":"184","author":"KB Gordon","year":"2021","unstructured":"Gordon KB, Warren RB, Gottlieb AB, et\u00a0al. Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2). Br J Dermatol. 2021;184(4):652\u201362.","journal-title":"Br J Dermatol"},{"key":"861_CR9","unstructured":"Electronic Medicines Compendium: Cimzia. Available at: http:\/\/www.medicines.org.uk\/emc\/medicine\/32367 [last accessed Apr 29 2022]."},{"key":"861_CR10","unstructured":"FDA: Cimzia Prescribing Information. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/125160s237lbl.pdf [last accessed Apr 29 2022]."},{"issue":"2","key":"861_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","volume":"77","author":"X Mariette","year":"2018","unstructured":"Mariette X, F\u00f6rger F, Abraham B, et\u00a0al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77(2):228\u201333.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"861_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/jdv.15258","volume":"33","author":"A Blauvelt","year":"2019","unstructured":"Blauvelt A, Reich K, Lebwohl M, et\u00a0al. Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials. J Eur Acad Dermatol. 2019;33(3):546\u201352.","journal-title":"J Eur Acad Dermatol"},{"issue":"2","key":"861_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jaad.2018.04.012","volume":"79","author":"AB Gottlieb","year":"2018","unstructured":"Gottlieb AB, Blauvelt A, Tha\u00e7i D, et\u00a0al. Certolizumab pegol for the treatment of chronic plaque psoriasis: results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2). J Am Acad Dermatol. 2018;79(2):302\u201314.e6.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"861_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jaad.2018.04.013","volume":"79","author":"M Lebwohl","year":"2018","unstructured":"Lebwohl M, Blauvelt A, Paul C, et\u00a0al. Certolizumab pegol for the treatment of chronic plaque psoriasis: results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT). J Am Acad Dermatol. 2018;79(2):266\u201376.e5.","journal-title":"J Am Acad Dermatol."},{"issue":"12","key":"861_CR15","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1111\/jdv.17486","volume":"35","author":"RB Warren","year":"2021","unstructured":"Warren RB, Lebwohl M, Sofen H, et\u00a0al. Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial. J Eur Acad Dermatol Venereol. 2021;35(12):2398\u2013408.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"861_CR16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/bjd.19314","volume":"184","author":"A Blauvelt","year":"2021","unstructured":"Blauvelt A, Paul C, van de Kerkhof P, et\u00a0al. Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies. Br J Dermatol. 2021;184(4):640\u201351.","journal-title":"Br J Dermatol"},{"issue":"3","key":"861_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology life quality index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"861_CR18","unstructured":"Maruish M KM, Bjorner J, Gandek B, Turner-Bowker DM, Ware JE. User\u2019s manual for the SF-36v2 Health Survey (3rd ed.). Lincoln, RI: QualityMetric Incorporated [Internet]. 2011."},{"key":"861_CR19","unstructured":"EuroQol. EQ-5D User Guides. Available at https:\/\/euroqol.org\/publications\/user-guides\/ [last accessed Apr 29 2022]."},{"key":"861_CR20","unstructured":"Reilly Associates. WPAI Scoring. Available at http:\/\/www.reillyassociates.net\/wpai_scoring.html [last accessed Apr 29 2022]."},{"issue":"11","key":"861_CR21","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3390\/ijms18112427","volume":"18","author":"P Gisondi","year":"2017","unstructured":"Gisondi P, Del Giglio M, Girolomoni G. Treatment approaches to moderate to severe psoriasis. Int J Mol Sci. 2017;18(11):2427.","journal-title":"Int J Mol Sci"},{"key":"861_CR22","doi-asserted-by":"crossref","unstructured":"Stoye G, Zaranko, B. Institute for Fiscal Studies: how accurate are self-reported diagnoses? Comparing self-reported health events in the English Longitudinal Study of Ageing with administrative hospital records. Available at: https:\/\/ifs.org.uk\/publications\/14864 [last accessed Apr 29 2022]. 2020.","DOI":"10.1920\/wp.ifs.2020.1320"}],"updated-by":[{"DOI":"10.1007\/s13555-023-00934-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000}}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00861-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T16:03:51Z","timestamp":1719504231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00861-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00861-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s13555-023-00934-y","asserted-by":"object"}]},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"5 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Volume and pages updated in header","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13555-023-00934-y","URL":"https:\/\/doi.org\/10.1007\/s13555-023-00934-y","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}